Rennova Health, Inc.
RNVA
$0.00
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -1.74% | 161.11% | -166.30% |
| Total Depreciation and Amortization | -- | -- | -20.19% | 0.43% | 0.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 31.64% | -747.48% | 53.25% |
| Change in Net Operating Assets | -- | -- | -3.54% | -26.87% | 365.32% |
| Cash from Operations | -- | -- | 20.35% | 2,074.77% | 174.53% |
| Capital Expenditure | -- | -- | -55,025.00% | 55.56% | 97.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 13.62% | -368.30% | 74.27% |
| Cash from Investing | -- | -- | -46.83% | -363.57% | 76.61% |
| Total Debt Issued | -- | -- | -10.77% | 494.66% | -152.34% |
| Total Debt Repaid | -- | -- | -168.71% | -1,174.70% | 82.41% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -268.76% | 179.03% |
| Cash from Financing | -- | -- | -791.76% | -18.40% | -119.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -150.81% | 521.48% | -591.10% |
